SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-067829
Filing Date
2023-12-04
Accepted
2023-12-04 17:15:32
Documents
4
Period of Report
2024-01-30

Document Format Files

Seq Description Document Type Size
1 PRE 14A itrm_prelim_proxy_pre-em.htm PRE 14A 201134
2 GRAPHIC img98815964_0.jpg GRAPHIC 3850
3 GRAPHIC img98815964_1.jpg GRAPHIC 87295
4 GRAPHIC img98815964_2.jpg GRAPHIC 239693
  Complete submission text file 0000950170-23-067829.txt   657652
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38503 | Film No.: 231464299
SIC: 2834 Pharmaceutical Preparations